|
 |
 |
Welcome to the bioproductivity company!
ERA Biotech develops and implements next-generation, cell-based biomanufacturing technologies. Our Zera® and StorPro® tools enable performance gains in most standard eukaryotic culture systems used today for production of protein drugs, enzymes and other biological products.
Zera® assembler peptides and StorPro® designed storage organelles are true “disruptive” technologies that improve the way recombinant proteins are produced and purified. They:
- enable difficult-to-express proteins (allowing the accumulation of normally labile and cytotoxic peptide/proteins)
- simplify and accelerate downstream processing
- make possible high product titers in upstream production
- create novel bioencapsulation and biopresentations options for vaccines and pharmaceuticals
Product opportunities enabled by ERA Biotech include biopharmaceuticals, oral and injectable vaccines, highly potent enzymes, and other protein-based applicationsin the health, industrial, bioenergy and nutrition sectors.
|
|
|
|
|
|
|
|
|
|
|